about
Stem Cell Strategies to Evaluate Idiosyncratic Drug-induced Liver InjuryPharmacogenomics: the promise of personalized medicineSummary of information on human CYP enzymes: human P450 metabolism data.Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity.Investigating the Role of Plasma Glucose Concentration as a Phenotypic Marker for CYP2C9 Genetic Variants, in the Diabetic Population of GujaratPharmacogenetic screening for susceptibility to fetal malformations in women.How to manage individualized drug therapy: application of pharmacogenetic knowledge of drug metabolism and transport.Understanding the interaction between environmental exposures and molecular events in colorectal carcinogenesis.Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.1998 ASHG presidential address. Making genomic medicine a realityEnzymatic Mechanisms Involved in Phenanthrene Degradation by the White Rot Fungus Pleurotus ostreatusGenetic polymorphisms of cytochrome P450 enzymes and the effect on interindividual, pharmacokinetic variability in extensive metabolizers.Differences in drug pharmacokinetics between East Asians and Caucasians and the role of genetic polymorphisms.Expression of CYP2A6, CYP2D6 and CYP4A11 Polymorphisms in COS7 Mammalian Cell Line.Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment.Biotransformation of xenobiotics in the human colon and rectum and its association with colorectal cancer.CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.Traditional Medicine to Modern Pharmacogenomics: Ayurveda Prakriti Type and CYP2C19 Gene Polymorphism Associated with the Metabolic VariabilityGenetic polymorphism of cytochrome P450 1A1 (Cyp1A1) and glutathione transferases (M1, T1 and P1) among Africans.Cytochrome p450 1Al gene polymorphisms in patients with psoriatic arthritis.
P2860
Q26781923-67FE44E3-2861-4C9A-837C-A7A411BA669EQ28210286-00F2CA6D-BD3C-4DB6-B475-E1EA61E7B20DQ32103802-1135D18A-B2B9-4139-897B-FE44EB90E074Q33538523-A9D5B75B-9052-43B8-88AD-BC19F25435B9Q33555327-26245AAD-9A08-4399-A847-4BC3CA207AA9Q33941950-C7091AC2-4D18-4FEC-AF39-20A716D1A7C9Q34093093-A109E872-66F0-4843-947B-5AC92D0FCF19Q34311096-98491440-13D7-4FCF-9D81-1ADE8643C2C9Q34331552-F525665A-38C9-466A-9164-68CCCC4EE6D5Q34388472-B36A6CA0-3283-48F3-9BD8-B510EE528A4DQ34424230-FBBBC1D5-10EA-4789-9CA8-67032CCC014CQ35753607-10E47A9F-2FC0-4C36-9F96-88CAC022D941Q35876954-F63B74D9-7CE7-4A0A-B1F2-73A0203E911BQ37326678-C2A63734-0531-483E-8CA6-09C4288C6C1AQ37775981-4157ED83-8F3E-4143-B34E-FA8150E23065Q38357424-1A31F585-96FC-4FBB-BA94-B3A1671A9F3BQ38496627-4B3546EC-F46F-41BE-A448-7B05487B27E3Q41877081-37910451-173A-4911-AB2C-66100735EFADQ43949916-C0F6B9D1-08AF-49D3-A39D-7E0F29619B24Q47655039-BED58D33-E637-4E62-910E-F7BF93AC2A07
P2860
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Molecular basis of polymorphic drug metabolism.
@en
type
label
Molecular basis of polymorphic drug metabolism.
@en
prefLabel
Molecular basis of polymorphic drug metabolism.
@en
P356
P1476
Molecular basis of polymorphic drug metabolism.
@en
P2093
P2888
P304
P356
10.1007/BF00195139
P577
1995-11-01T00:00:00Z